The common presenting symptoms among individuals with HCM include dyspnea, angina, and presyncope or syncope. Chest pain may occur at rest or be precipitated by exertion or, among those with LVOTO ...

The apical pulse is the most accurate place to measure your heart rate. Learn how to find this pulse site, check it, and interpret the results. ... Hypertrophic cardiomyopathy, which causes thickening ...

Hypertrophic cardiomyopathy, also called HCM, is the leading cause of sudden cardiac death in young athletes, sometimes with no warning signs. It is characterized by the thickening and stiffening of ...

The past 12 months mark a milestone year for the discipline of sports and exercise cardiology.We have seen the publication of two major guideline documents for athletes: the 2025 American Heart Associ ...

Hypertrophic cardiomyopathy (HCM) is a condition that thickens some of the heart’s muscles, making it harder to pump blood. Hypertrophic cardiomyopathy (HCM) usually affects the ventricular ...

Hypertrophic cardiomyopathy (HCM) is an uncommon disease with significant consequences. Since the 1950s, major strides in understanding its etiology and pathogenesis have led to improved ...

A new PET/CT imaging technique that visualizes activated fibroblasts in the heart muscle enables early detection of multiple forms of cardiomyopathy, according to research presented at the Society of ...

'End-stage' hypertrophic cardiomyopathy (HCM) is one of the most serious manifestations of HCM, yet its etiology remains poorly understood. Here, Yacoub et al. discuss recent advances in our ...

The efficacy data of aficamten in obstructive HCM patients with mild symptoms from SEQUOIA-HCM were simultaneously published ...

Stress-induced cardiomyopathy—also known as Takotsubo cardiomyopathy, apical ballooning syndrome, or ampulla cardiomyopathy—is an acute, reversible condition characterized by LV systolic ...

Who has won all four grand slams in the same year? The term 'Grand Slam' actually refers to the achievement of winning all four tournaments in the same year.

Capricor Therapeutics has completed its US marketing application for deramiocel, a cell therapy the US biotech hopes will become the first approved treatment for cardiomyopathy associated with ...